Tag Archives: United States

There will be enough Covid vaccines for the ‘entire U.S. adult population by June,’ doctor says

Johnson & Johnson board member Dr. Mark McClellan told CNBC Friday that there could be enough vaccinations for the entire U.S. adult population by the summer. 

“Assuming all of the close review of the J&J data all pans out, we’re going to have the capacity between Moderna, Pfizer, J&J, to have enough vaccines available by June for the entire U.S. adult population,” McClellan, a former FDA commissioner, said on “The News with Shepard Smith.” 

The U.S. plans to buy 200 million Covid vaccine doses from Moderna and Pfizer. The Department of Health and Human Services will boost its vaccine supply to states from 8.6 million to a minimum of 10 million doses per week. So far, states have received more than 49 million doses, but only about half of those have actually ended up in people’s arms, according to the Centers for Disease Control and Prevention. The agency reports that the U.S. is administering a little more than a million shots every day.

McClellan that the U.S. should significantly increase the amount of shots administered per day and “get our capacity for doing vaccinations up closer to 3 million doses per day.”

The United States has ordered 100 million doses of the J&J vaccine, which the company plans to deliver by June. J&J plans to file for emergency use authorization next week. If J&J’s vaccine is authorized by the FDA, it would be the third vaccine approved for emergency use in the U.S. Pfizer’s vaccine was authorized by the FDA on Dec. 11, and Moderna’s was authorized a week later.

The J&J vaccine efficacy numbers were lower than those for Pfizer and Moderna. Pfizer’s vaccine was found to be 95% effective against preventing Covid-19, while Moderna’s was found to be about 94% effective. J&J’s vaccine was found to be 66% effective overall in preventing moderate to severe Covid.

Host Shepard Smith asked McClellan about the lower efficacy numbers compared to Pfizer and Moderna, and he explained to Smith that “we’re fighting a different virus today than we were three months ago when previous trials were done.”

Additionally, J&J ran its trial across three continents and the level of protection varied by region. Its vaccine demonstrated overall, 72% effectiveness in the United States and 66% in Latin America. In South Africa, where the dangerous B.1.351 strain of Covid caused a surge in cases, the J&J  vaccine demonstrated 57% effectiveness.

“Unfortunately, we’re probably going to be fighting a different virus three months from now, so most important in winning this battle, is getting as many people vaccinated as possible,” said McClellan. “The faster we get shots in arms, the more people we get vaccinated here in this country and around the world, the better we’re going to do in containing that further spread and the further damage from Covid.”

Read original article here

J&J vaccine adds to COVID-19 armoury, includes South African variant

(Reuters) – Johnson & Johnson said on Friday that its single-dose vaccine was 66% effective in preventing COVID-19 in a large global trial against multiple variants, giving health officials another weapon to tackle the pandemic.

In the trial of nearly 44,000 volunteers, the level of protection against moderate and severe COVID-19 varied from 72% in the United States, to 66% in Latin America and just 57% in South Africa, from where a worrying variant has spread.

The data showed that the vaccine’s effect on the South Africa variant was diminished compared to the unaltered virus, but infectious disease and public health experts said it can still help contain the virus spread and prevent deaths.

Midstage trial data from Novavax on Thursday also documented lower effectiveness in South Africa.

Rival shots from Pfizer/BioNTech and Moderna were both around 95% effective in preventing symptomatic illness in pivotal trials when given in two doses.

Those trials were conducted mainly in the United States and before the emergence of new variants. These mean that the world is racing against time and with limited supplies to vaccinate as many people as possible, and quickly, to prevent virus surges.

COVID-19 is rising in 37 countries and infections have surpassed 101 million globally.

Top U.S. infectious disease specialist Anthony Fauci said the world needs to vaccinate quickly to try to get ahead of these changes in the virus.

“It’s really a wake up call for us to be nimble and to be able to adjust as this virus will continue for certain to evolve,” Fauci said.

J&J’s main goal was the prevention of moderate to severe COVID-19, and the vaccine was 85% effective in stopping severe disease and preventing hospitalization across all geographies and against multiple variants 28 days after immunization.

That “will potentially protect hundreds of millions of people from serious and fatal outcomes of COVID-19,” Paul Stoffels, J&J’s chief scientific officer, said.

J&J shares were down 4% at $162.7 at 1700 GMT, with some Wall Street analysts saying its vaccine’s effectiveness was below those of rivals. Moderna’s stock gained 8% to $172.80.

SEEKING APPROVAL

J&J plans to seek emergency use authorization from the U.S. Food and Drug Administration next week and will soon follow up with the European Union and the rest of the world.

It has said it plans to deliver 1 billion doses of the vaccine, which it will make in the United States, Europe, South Africa and India, in 2021.

Public health officials are counting on it to increase much-needed supply and simplify immunization in the United States, which has a deal to buy 100 million doses of J&J’s vaccine and an option for an additional 200 million.

J&J said the vaccine would be ready immediately upon emergency approval, but Stoffels declined to say how many doses.

“The key is not only overall efficacy but specifically efficacy against severe disease, hospitalization, and death,” said Walid Gellad, a health policy associate professor at the University of Pittsburgh.

J&J’s vaccine uses a common cold virus to introduce coronavirus proteins into cells and trigger an immune response, whereas the Pfizer/BioNTech and Moderna vaccines employ a new technology called messenger RNA.

Unlike these vaccines, J&J’s does not require a second shot weeks after the first or need to be kept frozen, making it a strong candidate for use in parts of the world where transportation and cold storage present problems.

“Most countries are still desperate to get their hands on doses, regardless of whether or not the vaccine is considered highly effective. Moderately effective will do just fine for now,” Michael Breen, Director of Infectious Diseases and Ophthalmology at research firm GlobalData, said.

‘OVERWHELMED’

Several studies have emerged this month showing that a South African variant has mutated in areas of the virus that are key targets of vaccines, reducing their efficacy.

“What we are learning is there is different efficacy in different parts of the world,” Stoffels told Reuters.

In a sub-study of 6,000 volunteers in South Africa, Stoffels said, the J&J vaccine was 89% effective at preventing severe disease. In the South Africa portion of the trial, 95% of cases were infections with the South African variant.

“I am overwhelmed by the fact that this vaccine protected against severe disease even in South Africa,” said Glenda Gray, the joint lead investigator of the South African vaccine trial.

In the J&J trial, which was conducted in eight countries, 44% of participants were from the United States, 41% from Central and South America and 15% from South Africa. Just over a third of the volunteers were over 60.

Reporting by Julie Steenhuysen; Additional reporting by Manas Mishra, Dania Nadeem and Manojna Maddipatla in Bengalaru, Rebecca Spalding and Michael Erman in New York and Promit Mukherjee in Johannesburg; Writing by Alexander Smith; Editing by Peter Henderson, Edwina Gibbs, Keith Weir and Caroline Humer

Read original article here

DOJ investigating SpaceX after hiring discrimination complaint

A Falcon 9 rocket launches the Transporter-1 mission in January 2021.

SpaceX

The U.S. Department of Justice is investigating Elon Musk’s SpaceX over whether the company discriminates against non-U.S. citizens in its hiring practices, according to court documents filed on Thursday.

The DOJ’s division of Immigrant and Employee Rights received a complaint of employment discrimination from a non-U.S. citizen claiming that the company discriminated against him based on his citizenship status.

“The charge alleges that on or about March 10, 2020, during the Charging Party’s interview for the position of Technology Strategy Associate, SpaceX made inquiries about his citizenship status and ultimately failed to hire him for the position because he is not a U.S. citizen or lawful permanent resident,” DOJ attorney Lisa Sandoval wrote in a complaint filed Thursday.

SpaceX did not immediately respond to CNBC’s request for comment. The Department of Justice declined to comment.

SpaceX headquarters in Los Angeles, California.

AaronP/Bauer-Griffin | GC Images | Getty Images

The Immigrant and Employee Rights (IER) division says it notified SpaceX via email on June 8 that it had opened an investigation, requesting SpaceX to provide information and documents related to its hiring and employment eligibility verification processes.

The complaint says SpaceX responded in August, sending the DOJ a Form I-9 spreadsheet of information about employees dating back to June 2019. But SpaceX refused the DOJ’s request “to produce any Form I-9 supporting documentation, such as copies of employees’ passports, driver’s licenses, or Social Security cards,” Sandoval wrote.

IER then obtained a subpoena on Oct. 7, but the complaint claims that SpaceX refused to produce the subpoenaed documents.

SpaceX filed a petition with a DOJ administrative tribunal to dismiss the subpoena on grounds that it exceeded the scope of IER’s authority, but that petition was denied, and SpaceX was ordered to comply. IER says SpaceX on Dec. 11 acknowledged that the order, but told IER “that it ‘does not intend to produce any additional information in response to the administrative subpoena.'”

The DOJ’s IER argues that the subpoenaed documents are relevant because they show the extent to which SpaceX hires non-U.S. citizens, and says it’s not burdensome, although SpaceX has told the IER that it would have to retrieve each document manually.

The Department of Justice is requesting an order from the court to require SpaceX comply with the subpoena within two weeks.

Subscribe to CNBC PRO for exclusive insights and analysis, and live business day programming from around the world.

Read original article here

Starbucks (SBUX) Q1 2021 earnings top estimates

Kevin Johnson, CEO, Starbucks

Scott Mlyn | CNBC

Starbucks on Tuesday reported that its U.S. same-store sales fell 5% during its fiscal first quarter after a surge of new Covid-19 cases led to harsher dining restrictions.

The company also announced that COO Roz Brewer will be leaving Starbucks at the end of February to become chief executive of another publicly traded company. Her responsibilities will be split up among other members of the existing leadership team.

Shares fell more than 1% in extended trading.

Here’s what the company reported for the quarter ended Dec. 27 compared with what Wall Street was expecting, based on a survey of analysts by Refinitiv:

  • Earnings per share: 61 cents, adjusted, vs. 55 cents expected
  • Revenue: $6.75 billion vs. $6.93 billion expected

The company reported fiscal first-quarter net income of $622.2 million, or 53 cents per share, down from $885.7 million, or 74 cents per share, a year earlier.

Excluding items, the coffee giant earned 61 cents per share, topping the 55 cents per share expected by analysts surveyed by Refinitiv.

Net sales dropped 5% to $6.75 billion, falling short of expectations of $6.93 billion. Worldwide, the company’s same-store sales fell 5%. The chain saw 19% fewer transactions during the quarter, but the average ticket jumped 17%.

In the U.S., same-store sales fell by 5%. The company’s recovery in its home market was hampered by another surge of new Covid-19 cases as the temperatures grew colder. The number of Starbucks Rewards members who have been active in the last 90 days rose 15% to 21.8 million people.

In China, Starbucks’ second-largest market, same-store sales turned positive for the first time since the health crisis started. Its same-store sales rose 5%, although transactions still declined compared with the same time a year ago.

The company opened 278 net new cafes during the quarter and now has a footprint nearing 33,000 locations.

Next quarter, Starbucks is forecasting U.S. same-store sales growth of 5% to 10%. In China, same-store sales are expected to nearly double. It expects to earn 36 cents to 41 cents per share. On an adjusted basis, it’s projecting earnings per share of 45 cents to 50 cents.

The company also raised its outlook for its fiscal 2021 earnings. It now expects earnings per share between $2.42 to $2.62, up from its prior forecast of $2.34 to $2.54.

Read original article here

Merck ends its vaccine development; Google offers its offices for vaccination sites

CVS completes first round of vaccination at 8,000 U.S. nursing homes

A CVS pharmacy manager prepares a coronavirus disease (COVID-19) vaccine dose at the Soldiers’ Home in Holyoke, Massachusetts, December 29, 2020.

Hoang ‘Leon’ Nguyen | The Republican | Pool | via Reuters

CVS Health completed administering the first round of Covid-19 vaccination at roughly 8,000 U.S. nursing facilities, Reuters reports.

Administration of second doses was underway and expected to be completed within four weeks.

CVS Pharmacy has administered nearly 2 million doses to date but has a capacity for 20 million to 25 million shots a month, the company told Reuters, adding that its long-term care vaccination effort remains on track.

Terri Cullen

U.S. doesn’t know how much Covid vaccine it has, says CDC chief

The head of the Centers for Disease Control and Prevention warned on Sunday that the federal government doesn’t know how much coronavirus vaccine there is available to the country, adding yet another complication to the new administration’s efforts to mitigate the crisis, reports CNBC’s Amanda Macias.

“I can’t tell you how much vaccine we have, and if I can’t tell it to you then I can’t tell it to the governors and I can’t tell it to the state health officials,” CDC director Dr. Rochelle Walensky told “Fox News Sunday.”

“If they don’t know how much vaccine they’re getting not just this week but next week and the week after they can’t plan. They can’t figure out how many sites to roll out, they can’t figure out how many vaccinators that they need, and they can’t figure out how many appointments to make for the public,” Walensky said.

President Joe Biden has set a goal for the country to administer 100 million vaccines in the president’s first 100 days.

Fred Imbert

Merck ends its Covid vaccine program, citing inferior immune responses

A Merck sign in front of the company’s building in Summit, New Jersey.

Getty Images

Merck said it will end development of its two Covid-19 vaccines, Reuters reports.

In early trials, two of the company’s vaccines generated immune responses that were inferior to those seen in people who had recovered from Covid-19, as well as those reported for other Covid-19 vaccines, according to Reuters.

The drugmaker said it plans to focus its pandemic research on treatments, with initial efficacy data on an experimental oral antiviral expected by the end of March, the wire service said.

Terri Cullen

Google to open vaccine sites at its U.S. offices

American multinational technology company Google logo seen at Googleplex, the corporate headquarters complex of Google and its parent company Alphabet Inc.

Alex Tai | SOPA Images | LightRocket | Getty Images

Google will make some of its own facilities available to open new coronavirus vaccination sites in the U.S.

The company said it has partnered with health clinic chain One Medical and public health authorities to open vaccine sites in Los Angeles; San Francisco; Kirkland, Washington; and New York City. The tech giant also plans to open vaccine centers abroad.

Google also committed $100 million in advertising grants to the CDC Foundation, World Health Organization and nonprofits, as well as a $50 million investment aimed at helping public health agencies reach underserved communities with vaccine information.

Google said it will start including Covid-19 vaccination locations in Google Search and Maps in the coming weeks, starting with Arizona, Louisiana, Mississippi and Texas. The information will include details like whether an appointment or referral is required and if the location has a drive-thru.

—Ryan Browne

Read CNBC’s previous live coverage here:

Read original article here

Exclusive: China’s Huawei in talks to sell premium smartphone brands P and Mate – sources

(Reuters) – China’s Huawei Technologies Co Ltd is in early-stage talks to sell its premium smartphone brands P and Mate, two people with direct knowledge of the matter said, a move that could see the company eventually exit from the high-end smartphone-making business.

FILE PHOTO: The Huawei logo is seen at the IFA consumer technology fair, amid the coronavirus disease (COVID-19) outbreak, in Berlin, Germany September 3, 2020. REUTERS/Michele Tantussi

The talks between the world’s largest telecommunications equipment maker and a consortium led by Shanghai government-backed investment firms have been going on for months, the people said, declining to be identified as the discussions were confidential.

Huawei started to internally explore the possibility of selling the brands as early as last September, according to one of the sources. The two sources were not privy to the valuation placed on the brands by Huawei.

Shipments of Mate and P Series phones were worth $39.7 billion between Q3 2019 and Q3 2020, according to consultancy IDC.

However, Huawei has yet to make a final decision on the sale and the talks might not conclude successfully, according to the two sources, as the company is still trying to manufacture at home its in-house designed high-end Kirin chips which power its smartphones.

“Huawei has learned there are unsubstantiated rumours circulating regarding the possible sale of our flagship smartphone brands,” a Huawei spokesman said. “There is no merit to these rumours whatsoever. Huawei has no such plan.”

The Shanghai government said it was not aware of the situation and declined to comment further.

The potential sale of Huawei’s premium smartphone lines suggests the company has little hope that the new Biden administration will have a change of heart towards the supply chain restrictions placed on Huawei since May 2019, the two people said.

The Shanghai government-backed investment firms may form a consortium with Huawei’s dealers to take over the P and Mate brands, according to the second person, a similar model to the Honor deal. Huawei is also likely to keep its existing P& Mate management team for the new entity, if the deal goes through, the two people said.

OVERCOMING U.S. CURBS

Huawei, the world’s biggest telecoms equipment vendor and No.2 smartphone maker, last November announced the sale of its budget phone brand Honor to a consortium of 30 dealers led by a company backed by the Shenzhen government.

The second source said the all-cash sale fetched more than 100 billion yuan ($15.5 billion). Honor declined to comment.

The Honor sale was aimed at keeping the budget brand alive, as sanctions slapped on Huawei by the United States had hampered the unit’s supply chain and cut off the company’s access to key hardware like chips and software such as Alphabet Inc’s Google Mobile Services.

Huawei may have a similar objective in pursuing the sale of the mobile brands. The two sources said that Huawei’s latest plans for the two high-end brands were motivated by insufficient chip supplies.

Washington says that Huawei is a national security threat, which Huawei has repeatedly denied.

On Friday, Honor indicated that the goal of the spin-off had been reached by announcing it had formed partnerships with chip makers such as Intel and Qualcomm and launched a new phone.

Last year, the company’s Consumer Business Group Chief Executive Richard Yu said U.S. restrictions meant Huawei would soon stop making Kirin chips. Analysts expect its stockpile of the chips to run out this year.

Huawei’s HiSilicon division relies on software from U.S. companies such as Cadence Design Systems Inc or Synopsys Inc to design its chips and it outsources the production to Taiwan Semiconductor Manufacturing Co (TSMC), which uses equipment from U.S. companies.

The P and Mate phone series are among the top players in the higher-end smartphone market in China and compete with Apple’s iPhone, Xiaomi Corp’s Mi and Mix series and OPPO’s Find series.

The two brands contributed nearly 40% to Huawei’s total sales over the third quarter of 2020, according to market research firm Counterpoint.

Analysts have already noted recent insufficient supplies of the flagship P40 and Mate40 series due to a severe components shortage.

“We expect a continuous decline in sales of P and Mate series smartphones through Q1 2021,” said Flora Tang, an analyst at Counterpoint.

Reporting by Julie Zhu, Yingzhi Yang and David Kirton, Additional reporting by Brenda Goh; Editing by Sumeet Chatterjee & Shri Navaratnam

Read original article here

Need a lift? SpaceX launches record spacecraft in cosmic rideshare program

FILE PHOTO: SpaceX owner and Tesla CEO Elon Musk poses after arriving on the red carpet for the Axel Springer award, in Berlin, Germany, December 1, 2020. REUTERS/Hannibal Hanschke/Pool

(Reuters) – A veteran rocket from billionaire entrepreneur Elon Musk’s SpaceX aerospace company launched 143 spacecraft into space on Sunday, a new record for the most spaceships deployed on a single mission, according to the company.

The Falcon 9 rocket lifted off at 10 a.m. EST from the Space Launch Complex 40 at Cape Canaveral Space Force Station in Florida. It flew south along the eastern coast of Florida on its way to space, the company said.

The reusable rocket ferried 133 commercial and government spacecraft and 10 Starlink satellites to space – part of the company’s SmallSat Rideshare Program, which provides access to space for small satellite operators seeking a reliable, affordable ride to orbit, according to the company.

SpaceX delayed the launch one day because of unfavorable weather. On Jan. 22 Musk, also chief executive of Tesla Inc., wrote on Twitter: “Launching many small satellites for a wide range of customers tomorrow. Excited about offering low-cost access to orbit for small companies!”

SpaceX has previously launched to orbit more than 800 satellites of the several thousand needed to offer broadband internet globally, a $10 billion investment it estimates could generate $30 billion annually to help fund Musk’s interplanetary rocket program, called Starship.

Reporting by Helen Coster; Editing by Daniel Wallis

Read original article here

World leaders cheer US return to climate fight under Biden

BERLIN (AP) — World leaders breathed an audible sigh of relief that the United States under President Joe Biden is rejoining the global effort to curb climate change, a cause that his predecessor had shunned over the past four years.

British Prime Minister Boris Johnson and French President Emmanuel Macron were among those welcoming Biden’s decision to rejoin the the Paris climate accord, reversing a key Trump policy in the first hours of his presidency Wednesday.

“Rejoining the Paris Agreement is hugely positive news,” tweeted Johnson, whose country is hosting this year’s U.N. climate summit.

Macron said that with Biden, “we will be stronger to face the challenges of our time. Stronger to build our future. Stronger to protect our planet.”

The Paris accord, forged in the French capital in 2015, commits countries to put forward plans for reducing their emissions of greenhouse gases such as carbon dioxide, which is released from burning fossil fuels.

As president, Donald Trump questioned the scientific warnings about man-made global warming, at times accusing other countries of using the Paris accord as a club to hurt Washington. The U.S. formally left the pact in November.

“The United States departure from it has definitely diminished our capacities to change things, concretely to reduce the greenhouse gas emissions,” said Paris Mayor Anne Hidalgo.

“Now we are dealing with an administration that is conscious of what is at stake and that is very committed to use the voice of the United States, a voice that is very powerful on the international level,” she said.

Biden put the fight against climate change at the center of his presidential campaign and on Wednesday immediately launched a series of climate-friendly efforts to bring Washington back in step with the rest of the world on the issue.

“A cry for survival comes from the planet itself,” Biden said in his inaugural address. “A cry that can’t be any more desperate or any more clear now.”

Experts say any international efforts to keep global warming well below 2 degrees Celsius (3.6 Fahrenheit), ideally 1.5C (2.7F), as agreed in the Paris accord would struggle without the contribution of U.S., which is the world’s second biggest carbon emitter.

Scientists say time is running out to reach that goal because the world has already warmed 1.2 C (2.2 F) since pre-industrial times.

Of particular importance is deforestation in the vast Amazon rainforest. Brazilian President Jair Bolsonaro has faced criticism from global leaders, including Biden before his election victory, and non-profit organizations for rising deforestation.

Bolsonaro has been dismissive of international efforts to steer Brazil’s management of the huge rainforest, saying its resources must be harnessed to support growth and economic development. Still, he sent a letter to Biden on Wednesday urging that the two countries continue their “partnership in favor of sustainable development and protection of the environment, especially of the Amazon.”

“I stress that Brazil has shown its commitment with the Paris Accord after the introduction of its new national goals,” Bolsonaro added in the letter, which he published on his social media channels.

Italy said the U.S. return to the Paris accord would help other countries reach their own climate commitments. “Italy looks forward to working with the U.S. to build a sustainable planet and ensure a better future for the next generations,” Premier Giuseppe Conte tweeted.

The Vatican, too, was clearly pleased given the decision aligns with Pope Francis’ environmental agenda and belief in multilateral diplomacy. In a front-page editorial in Wednesday’s L’Osservatore Romano, Vatican deputy editorial director Alessandro Gisotti noted that Biden’s decision to rejoin Paris “converges with Pope Francis’ commitment in favor of the custody of our common home.”

German Chancellor Angela Merkel was more muted in her reaction, noting on Thursday that her government would “probably have a more similar opinion” with Biden on issues such as the Paris climate accord, migration and the World Health Organization.

Youth activists who have been at the forefront of demanding leaders take the threat of global warming seriously said they now want to see concrete action from Washington.

“Many countries signed the Paris Agreement and they are still part of the Paris Agreement, but they make very free interpretations of what that implies,” said Juan Aguilera, one of the organizers of the Fridays for Future movement in Spain. “In many cases, signing it has become a show, because at the end of the day the concrete measures that are being taken, at least in the short term, are not satisfactory.”

Biden has appointed a large team to tackle climate change both on the domestic and international front. Former Secretary of State John Kerry, named as the president’s special climate envoy, on Thursday took part in a virtual event with Italian industry at which he touted the ‘green economy’ as an engine for jobs and said the U.S. planned to make up for time lost over the past four years.

Organizers of a meeting Monday on adapting to climate change said they hoped Kerry would take part, too, and Biden himself has talked about inviting world leaders to a summit on the issue within his first 100 days in office.

Over the coming months the U.S. allies and rivals will closely watch to see by how much the administration offers to cut its emissions in the coming decade. A firm number is expected to be announced before the U.N. climate summit taking place in Glasgow, Scotland, in November.

Veterans of such gatherings noted the formidable diplomatic clout that the U.S. has managed to bring to them in the past.

Farhana Yamin, a British lawyer who served as adviser to the Marshall Islands in the Paris negotiations, said she left the climate talks in 2018 feeling “disillusioned” not only by the U.S. withdrawal but also by how other countries, including her own, were failing to live up to the agreed goals.

“I wish there were more progress here in the UK,” she said, adding she hoped that the change in the White House would mean others would increase their ambition on climate, too. “The U.S. always has massive influence on its allies.”

___

Associated Press writer Karl Ritter and Nicole Winfield in Rome, Oleg Cetinic in Paris, Aritz Parra in Madrid and David Biller in Rio de Janeiro contributed to this report.

___

Follow AP’s climate coverage at https://www.apnews.com/Climate

Read original article here